As filed with the Securities and Exchange Commission on February 26, 2008.

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 


 

FORM 8-K
 

 

CURRENT REPORT
 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

February 26, 2008

 


 

MEDAREX, INC.

(Exact name of registrant as specified in its charter)

 


 

New Jersey

(State of other jurisdiction of incorporation)

 

0-19312

(Commission File Number)

 

22-2822175

(IRS Employer Identification No.)

 

707 State Road, Princeton, N.J. 08540-1437

(Address of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (609) 430-2880

 

Not Applicable

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

 

o            Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02.                                        Results of Operations and Financial Condition.

 

On February 26, 2008, Medarex, Inc. issued a press release to report the company’s financial results for the quarter and year ended December 31, 2007.  A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.  No additional information is included in this Current Report on Form 8-K.

 

The information included in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed “filed” for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

 

Item 9.01                                           Financial Statements and Exhibits.

 

(c)                                Exhibits.  The following material is filed as an exhibit to this Current Report on Form 8-K:

 

Exhibit
Number

 

 

 

 

 

99.1

 

Press Release issued February 26, 2008

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

MEDAREX, INC.

 

Registrant

 

 

 

 

Date: February 26, 2008

By:

 /s/ Christian S. Schade

 

Christian S. Schade

 

Senior Vice President and Chief Financial

 

Officer

 

4



 

EXHIBIT INDEX

 

Exhibit
Number

 


Description

 

Page
Number

 

 

 

 

 

99.1

 

Press Release issued February 26, 2008

 

 

 

5